113 related articles for article (PubMed ID: 33557650)
1. Clinical effects of morning and afternoon radiotherapy on high-grade gliomas.
Sapienza LG; Nasra K; Berry R; Danesh L; Little T; Abu-Isa E
Chronobiol Int; 2021 May; 38(5):732-741. PubMed ID: 33557650
[TBL] [Abstract][Full Text] [Related]
2. Sequential proton boost after standard chemoradiation for high-grade glioma.
Adeberg S; Bernhardt D; Harrabi SB; Uhl M; Paul A; Bougatf N; Verma V; Unterberg A; Wick W; Haberer T; Combs SE; Herfarth K; Debus J; Rieken S
Radiother Oncol; 2017 Nov; 125(2):266-272. PubMed ID: 29050959
[TBL] [Abstract][Full Text] [Related]
3. Using Smaller-Than-Standard Radiation Treatment Margins Does Not Change Survival Outcomes in Patients with High-Grade Gliomas.
Guram K; Smith M; Ginader T; Bodeker K; Pelland D; Pennington E; Buatti JM
Pract Radiat Oncol; 2019 Jan; 9(1):16-23. PubMed ID: 30195927
[TBL] [Abstract][Full Text] [Related]
4. Narrative review of palliative hypofractionated radiotherapy for high grade glioma.
Saeed H; Tseng YD; Lo SS
Ann Palliat Med; 2021 Jan; 10(1):846-862. PubMed ID: 33040565
[TBL] [Abstract][Full Text] [Related]
5. External beam radiation dose escalation for high grade glioma.
Khan L; Soliman H; Sahgal A; Perry J; Xu W; Tsao MN
Cochrane Database Syst Rev; 2016 Aug; (8):CD011475. PubMed ID: 27541334
[TBL] [Abstract][Full Text] [Related]
6. Particle radiation therapy in the management of malignant glioma: Early experience at the Shanghai Proton and Heavy Ion Center.
Kong L; Wu J; Gao J; Qiu X; Yang J; Hu J; Hu W; Mao Y; Lu JJ
Cancer; 2020 Jun; 126(12):2802-2810. PubMed ID: 32167589
[TBL] [Abstract][Full Text] [Related]
7. Clinical analysis of the efficacy of radiation therapy for primary high-grade gliomas guided by biological rhythms.
Niu Z; Yang Z; Sun S; Zeng Z; Han Q; Wu L; Bai J; Li H; Xia H
Transl Oncol; 2024 May; 45():101973. PubMed ID: 38705052
[TBL] [Abstract][Full Text] [Related]
8. Corpus callosum involvement and postoperative outcomes of patients with gliomas.
Chen KT; Wu TW; Chuang CC; Hsu YH; Hsu PW; Huang YC; Lin TK; Chang CN; Lee ST; Wu CT; Tseng CK; Wang CC; Pai PC; Wei KC; Chen PY
J Neurooncol; 2015 Sep; 124(2):207-14. PubMed ID: 26033546
[TBL] [Abstract][Full Text] [Related]
9. Observation versus radiotherapy with or without temozolomide in postoperative WHO grade II high-risk low-grade glioma: a retrospective cohort study.
Wang J; Yan L; Ai P; He Y; Guan H; Wei Z; He L; Mu X; Liu Y; Peng X
Neurosurg Rev; 2021 Jun; 44(3):1447-1455. PubMed ID: 32529528
[TBL] [Abstract][Full Text] [Related]
10. Subventricular zone involvement at recurrence is a strong predictive factor of outcome following high grade glioma reirradiation.
Attal J; Chaltiel L; Lubrano V; Sol JC; Lanaspeze C; Vieillevigne L; Latorzeff I; Cohen-Jonathan Moyal E
J Neurooncol; 2018 Jan; 136(2):413-419. PubMed ID: 29273890
[TBL] [Abstract][Full Text] [Related]
11. Comparison of carbon ion radiotherapy to photon radiation alone or in combination with temozolomide in patients with high-grade gliomas: explorative hypothesis-generating retrospective analysis.
Combs SE; Bruckner T; Mizoe JE; Kamada T; Tsujii H; Kieser M; Debus J
Radiother Oncol; 2013 Jul; 108(1):132-5. PubMed ID: 23932193
[TBL] [Abstract][Full Text] [Related]
12. The impact of adjuvant therapy for patients with high-risk diffuse WHO grade II glioma.
Youland RS; Kreofsky CR; Schomas DA; Brown PD; Buckner JC; Laack NN
J Neurooncol; 2017 Dec; 135(3):535-543. PubMed ID: 28836106
[TBL] [Abstract][Full Text] [Related]
13. Concurrent hyperthermia and re-irradiation for recurrent high-grade gliomas.
Heo J; Kim SH; Oh YT; Chun M; Noh OK
Neoplasma; 2017; 64(5):803-808. PubMed ID: 28592133
[TBL] [Abstract][Full Text] [Related]
14. The outcomes of concomitant radiation plus temozolomide followed by adjuvant temozolomide for newly diagnosed high grade gliomas: the preliminary results of single center prospective study.
Shawky H; Abo Hamar AH; Galal S; Zakaria F; El-Shorbagy D
J Egypt Natl Canc Inst; 2009 Jun; 21(2):107-19. PubMed ID: 21057562
[TBL] [Abstract][Full Text] [Related]
15. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
[TBL] [Abstract][Full Text] [Related]
16. Management of pediatric intracranial low-grade gliomas: long-term follow-up after radiation therapy.
Huynh-Le MP; Walker AJ; Burger PC; Jallo GI; Cohen KJ; Wharam MD; Terezakis SA
Childs Nerv Syst; 2016 Aug; 32(8):1425-30. PubMed ID: 27179530
[TBL] [Abstract][Full Text] [Related]
17. Outcome of children with centrally reviewed low-grade gliomas treated with chemotherapy with or without radiotherapy on Children's Cancer Group high-grade glioma study CCG-945.
Fouladi M; Hunt DL; Pollack IF; Dueckers G; Burger PC; Becker LE; Yates AJ; Gilles FH; Davis RL; Boyett JM; Finlay JL
Cancer; 2003 Sep; 98(6):1243-52. PubMed ID: 12973849
[TBL] [Abstract][Full Text] [Related]
18. Survival gain with re-Op/RT for recurred high-grade gliomas depends upon risk groups.
Chun SJ; Park SH; Park CK; Kim JW; Kim TM; Choi SH; Lee ST; Kim IH
Radiother Oncol; 2018 Aug; 128(2):254-259. PubMed ID: 29937212
[TBL] [Abstract][Full Text] [Related]
19. Hypofractionated Stereotactic Radiotherapy as a Salvage Therapy for Recurrent High-Grade Gliomas: Single-Center Experience.
Reynaud T; Bertaut A; Farah W; Thibouw D; Crehange G; Truc G; Vulquin N
Technol Cancer Res Treat; 2018 Jan; 17():1533033818806498. PubMed ID: 30343637
[TBL] [Abstract][Full Text] [Related]
20. Hypofractionated Stereotactic Radiation Therapy in Recurrent High-Grade Glioma: A New Challenge.
Navarria P; Ascolese AM; Tomatis S; Reggiori G; Clerici E; Villa E; Maggi G; Bello L; Pessina F; Cozzi L; Scorsetti M
Cancer Res Treat; 2016 Jan; 48(1):37-44. PubMed ID: 25761491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
